CompletedNot Applicable

Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Insufficiency.

Russia82 participantsStarted 2013-10

Plain-language summary

Compare the results of reconstruction and mitral valve replacement in the surgical treatment of obstructive hypertrophic cardiomyopathy with severe mitral insufficiency.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Able to sign Informed Consent and Release of Medical Information forms * Age ≥ 18 years * obstructive hypertrophic cardiomyopathy * surgically significant mitral insufficiency * II-IV (NYHA), * average systolic pressure gradient greater than 50 mm Hg. Art. at rest; * basal or medium ventricular obstruction Exclusion Criteria: * Related defect of the aortic valve; * Organic mitral valve disease (dysplasia, rheumatic fever, infective endocarditis); * Surgically significant coronary artery lesions; * Patients requiring implantation of a cardioverter-defibrillator

What they're measuring

The function of the mitral valve (mitral regurgitation return, prosthesis dysfunction)

Timeframe: one year

Trial details

NCT IDNCT02054221

SponsorMeshalkin Research Institute of Pathology of Circulation

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2015-05

View on ClinicalTrials.gov More Hypertrophic Obstructive Cardiomyopathy trials